0001085037-13-000155.txt : 20131105 0001085037-13-000155.hdr.sgml : 20131105 20131104180053 ACCESSION NUMBER: 0001085037-13-000155 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20131105 DATE AS OF CHANGE: 20131104 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: COUNTERPATH CORP CENTRAL INDEX KEY: 0001236997 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 200004161 STATE OF INCORPORATION: NV FISCAL YEAR END: 0430 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-79818 FILM NUMBER: 131190324 BUSINESS ADDRESS: STREET 1: 300-505 BURRARD STREET CITY: VANCOUVER STATE: A1 ZIP: V7X 1M3 BUSINESS PHONE: 604-320-3344 MAIL ADDRESS: STREET 1: 300-505 BURRARD STREET CITY: VANCOUVER STATE: A1 ZIP: V7X 1M3 FORMER COMPANY: FORMER CONFORMED NAME: COUNTERPATH SOLUTIONS, INC. DATE OF NAME CHANGE: 20050928 FORMER COMPANY: FORMER CONFORMED NAME: XTEN NETWORKS, INC DATE OF NAME CHANGE: 20040507 FORMER COMPANY: FORMER CONFORMED NAME: BROAD SCOPE ENTERPRISES INC DATE OF NAME CHANGE: 20030529 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: MATTHEWS TERENCE H CENTRAL INDEX KEY: 0001220385 FILING VALUES: FORM TYPE: SC 13D/A MAIL ADDRESS: STREET 1: 350 LEGGET DRIVE CITY: KANATA ONTARIO CANADA STATE: A6 ZIP: K2K 2W7 SC 13D/A 1 schedule13da.htm SCHEDULE 13D/A AMENDMENT NO. 6 schedule13da.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
 
SCHEDULE 13D/A
(Amendment No. 6)
Under the Securities Exchange Act of 1934
 

CounterPath Corporation
(Name of Issuer)
 
Common Stock
(Title of Class of Securities)
 
22228P 20 3
(CUSIP Number)
 
Paul Chiarelli
Secretary and Treasurer
Wesley Clover Corporation
390 March Road, Suite 110
Kanata, Ontario, Canada K2K 0G
Telephone: 613.271.5972
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
 
November 1, 2013
(Date of Event which Requires Filing of this Statement)

 
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(3), 240.13d-1(f) or 240.13d-1(g), check the following box. [  ]
 
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.
 
* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
 
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 
 

 

CUSIP No. 22228P 20 3
 
1.           Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
 
Dr. Terence H. Matthews
 
2.           Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [ X ]
(b) [     ]
 
3.           SEC Use Only
 
4.           Source of Funds (See Instructions):                                                                WC
 
5.           Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e):  [   ]
 
6.           Citizenship or Place of Organization:                                                                Canada
 
Number of Shares Beneficially Owned by Each Reporting Person With
 
7.           Sole Voting Power                                                         0
 
8.           Shared Voting Power                                     9,043,650 (1)(2)(3)(4)(5)
 
9.           Sole Dispositive Power                                                 0
 
10.         Shared Dispositive Power                           9,043,650 (1)(2)(3)(4)(5)
 
11.           Aggregate Amount Beneficially Owned by Each Reporting Person                              9,043,650 (1)(2)(3)(4)(5)
 
12.           Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)  [   ]
 
13.           Percent of Class Represented by Amount in Row (11)                                                            21.4%(6)
 
14.           Type of Reporting Person (See Instructions):                                                                           IN
 

 
(1)
Includes 8,366,025 Shares that were previously held indirectly by Dr. Matthews through Wesley Clover Corporation. Kanata Research Park Corporation (“Kanata”) and Wesley Clover Corporation amalgamated with the resulting company being Kanata.
 
(2)
Wesley Clover International Corporation is the sole shareholder of Kanata.  Dr. Matthews owns 99.999% of the issued and outstanding voting shares of Wesley Clover International Corporation.
 
(3)
Includes 260,000 Shares held by 346866 Canada Inc., a company wholly owned by Kanata.
 
(4)
Includes 18,000 Shares that may be acquired on the exercise of stock options held by Dr. Matthews.
 
(5)
Includes 132,625 Shares that may be acquired on the conversion of deferred share units held by Dr. Matthews.
 
(6)
Calculated based on the aggregate of 42,231,562 Shares, which consists of 42,080,937 Shares outstanding as of October 31, 2013, 132,625 shares that may be acquired on conversion of deferred share units within sixty days and 18,000 stock options exercisable within sixty days pursuant to Rule 13d-3 of the Act.

 
2

 

CUSIP No. 22228 P 20 3
 
1.           Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
 
Kanata Research Park Corporation
 
2.           Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [ X  ]
(b) [      ]
 
3.           SEC Use Only
 
4.           Source of Funds (See Instructions):                                                                WC
 
5.           Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e):  [   ]
 
6.           Citizenship or Place of Organization:                                                                Canada
 
Number of Shares Beneficially Owned by Each Reporting Person With
 
7.           Sole Voting Power                                                        0
 
8.           Shared Voting Power                                   8,633,025 (1)(2)
 
9.           Sole Dispositive Power                                                0
 
10.         Shared Dispositive Power                        8,633,025 (1)(2)
 
11.           Aggregate Amount Beneficially Owned by Each Reporting Person                           8,633,025 (1)(2)
 
12.           Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)  [   ]
 
13.           Percent of Class Represented by Amount in Row (11)                                                       20.5%(3)
 
14.           Type of Reporting Person (See Instructions):                                                                           CO
 

 
(1)
These Shares were previously held indirectly by Dr. Matthews through Wesley Clover Corporation.  Kanata and Wesley Clover Corporation amalgamated with the resulting company being Kanata.
 
(2)
Wesley Clover International Corporation is the sole shareholder of Kanata.  Dr. Matthews owns 99.999% of the issued and outstanding voting shares of Wesley Clover International Corporation.
 
(3)
Calculated based on 42,080,937 Shares outstanding as of October 31, 2013.
 

 


 
3

 

CUSIP No. 22228 P 20 3
 
1.           Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
 
3468666 Canada Inc.
 
2.           Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [ X ]
(b) [     ]
 
3.           SEC Use Only
 
4.           Source of Funds (See Instructions):                                                                WC
 
5.           Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e):  [   ]
 
6.           Citizenship or Place of Organization:                                                                Canada
 
Number of Shares Beneficially Owned by Each Reporting Person With
 
7.           Sole Voting Power                                                        0
 
8.           Shared Voting Power                                       260,000 (1)(2)
 
9.           Sole Dispositive Power                                                0
 
10.         Shared Dispositive Power                            260,000 (1)(2)
 
11.           Aggregate Amount Beneficially Owned by Each Reporting Person                               260,000 (1)(2)
 
12.           Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)  [   ]
 
13.           Percent of Class Represented by Amount in Row (11)                                                          0.6%(3)
 
14.           Type of Reporting Person (See Instructions):                                                                           CO
 

 
(1)
Dr. Matthews is the sole director and officer of 3468666 Canada Inc. and Kanata is the sole shareholder of 3468666 Canada Inc.
 
(2)
Wesley Clover International Corporation is the sole shareholder of Kanata.  Dr. Matthews owns 99.999% of the issued and outstanding voting shares of Wesley Clover International Corporation.
 
(3)
Calculated based on 42,080,937 Shares outstanding as of October 31, 2013.



 
4

 


 
This Schedule 13D is being filed on behalf of Dr. Terence H. Matthews (“Dr. Matthews”), Kanata Research Park Corporation (“Kanata”) and 3468666 Canada Inc. (“3468666” and, together with Dr. Matthews and Kanata, collectively, the “Reporting Persons”) relating to the shares of common stock of Counterpath Corporation, a corporation existing under the laws of the State of Nevada (the “Issuer”).
 
Item 1.                      Security And Issuer
 
This Statement relates to the shares of common stock (the “Shares”) of the Issuer.  The principal executive offices of the Issuer are located at Suite 300, One Bentall Centre, 505 Burrard Street, Vancouver, British Columbia, Canada V7X 1M3.
 
Item 2.                      Identity And Background
 
This statement is filed by the Reporting Persons.
 
Dr. Matthews’ business address is 390 March Road, Suite 110, Kanata, Ontario, Canada K2K 0G7. Dr. Matthews is Chairman of Mitel Networks Corporation.  Dr. Matthews is a citizen of Canada.
 
Kanata, a corporation existing under the laws of Canada, is a company that owns and manages commercial real estate in Ottawa. Kanata’s principal business and principal office address is 555 Legget Drive, Suite 206, Kanata, Ontario, Canada K2K 2X3.  Wesley Clover International Corporation owns 100% of the issued and outstanding voting shares of Kanata.  Dr. Matthews owns 99.999% of the issued and outstanding voting shares of Wesley Clover International Corporation.
 
3468666, a corporation existing under the laws of Canada, is an inactive company.  3468666’s principal business and principal office address is 555 Legget Drive, Suite 206, Kanata, Ontario, Canada K2K 2X3.  Kanata owns 100% of the issued and outstanding voting shares of 3468666.
 
None of the Reporting Persons nor any of their directors or executive officers has, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).
 
None of the Reporting Persons nor any of their directors or executive officers has, during the last five years, been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
 
Pursuant to Rule 13d-3 under the Act, by reason of his relationship with Kanata, Dr. Matthews may be deemed the beneficial owner of all of the Shares beneficially owned by Kanata.  Dr. Matthews and Kanata may be regarded as a group for purposes of Rule 13d-5 under the Act.
 
For information with respect to each executive officer and director of Kanata see Appendix A attached hereto which is specifically incorporated herein by reference in its entirety.
 
Item 3.                      Source and Amount of Funds or Other Consideration
 
Wesley Clover Corporation and Kanata amalgamated with Kanata being the resulting company.
 
 
5

 
Pursuant to a purchase and sale agreement (the “Agreement”) dated October 16, 2013 between the Matthew Family Trust #2 (the “Family Trust”) and Kanata, Kanata, among other things, purchased the one outstanding share of 3468666 held by the Family Trust in consideration for the total purchase price of $1.00.  The transfer of the outstanding share of 3468666 pursuant to the Agreement was completed on November 1, 2013.
 
Item 4.                      Purpose of Transaction
 
The Reporting Persons have acquired the Shares of the Issuer for investment purposes. In that connection, the Reporting Persons may have their representatives meet with management, directors or other shareholders of the Issuer from time to time to discuss the affairs of the Issuer. The Reporting Persons intend to monitor the business and affairs of the Issuer, including its financial performance, and depending upon these factors, market conditions and other factors, the Reporting Persons may acquire additional securities of the Issuer as they deem appropriate.  Alternatively, the Reporting Persons may dispose of some or all of the Shares in privately negotiated transactions or otherwise.
 
At this time and other than as described in Item 5 of this Schedule 13D, neither of the Reporting Persons nor, to their knowledge, any of their executive officers or directors, have the intention of acquiring additional Shares of the Issuer, although the Reporting Persons reserve the right to make additional purchases on the open market, in private transactions and from treasury.  Neither of the Reporting Persons nor, to their knowledge, any of their executive officers or directors, have any plans or proposals which relate to or would result in:
 
 
(a)
the acquisition by any person of additional securities of the Issuer, or the disposition of securities of the Issuer;
 
 
(b)
an extraordinary corporate transaction, such as a merger, reorganization of liquidation, involving the Issuer or any of its subsidiaries;
 
 
(c)
a sale of transfer of a material amount of assets of the Issuer or any of its subsidiaries;
 
 
(d)
any change in the present board of directors or management of the Issuer, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board;
 
 
(e)
any material change in the present capitalization or dividend policy of the Issuer;
 
 
(f)
any other material change in the Issuer’s business or corporate structure;
 
 
(g)
changes in the Issuer’s charter, bylaws or instruments corresponding thereto or other actions which may impede the acquisition of control of the Issuer by any person;
 
 
(h)
causing a class of securities of the Issuer to be delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association;
 
 
(i)
a class of equity securities of the Issuer becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Act; or
 
 
(j)
any action similar to any of those enumerated above.
 
 
6

 
Item 5.                      Interest in Securities of the Issuer
 
As of the date hereof, the Reporting Persons beneficially own the aggregate number and percentage of outstanding Shares set forth below:
 
Reporting Person
Aggregate Number of Shares
Beneficially Owned
Percentage of Outstanding
Common Shares
Dr. Matthews
9,043,650(1)(2)
21.4%(3)
Kanata
8,633,025(2)
20.5%(4)
3468666
260,000
0.6%(4)

(1)
Calculated based on the (i) 8,633,025 Shares owned by Kanata, (ii) 260,000 shares owned by 3468666, (iii) 18,000 Shares subject to stock options held by Dr. Matthews that are currently exercisable and (iv) 132,625 Shares subject to deferred share units held by Dr. Matthews that are currently convertible.
 
(2)
Pursuant to Rule 13d-3 under the Act, by reason of his relationship with Kanata as described in Item 2, Dr. Matthews may be deemed the beneficial owner of all of the Shares beneficially owned by Kanata.
 
(3)
Calculated based on the aggregate of 42,231,562 Shares, which consists of 42,080,937 Shares outstanding as of October 31, 2013, 132,625 shares that may be acquired on conversion of deferred share units within sixty days and 18,000 stock options exercisable within sixty days pursuant to Rule 13d-3 of the Act.
 
(4)
Calculated based on 42,080,937 Shares outstanding as of October 31, 2013.
 
Pursuant to the regulations promulgated under Section 13(d) of the Exchange Act, Dr. Matthews may be deemed to have shared power to vote or direct the vote and shared power to dispose or to direct the disposition of 8,893,025 Shares, which include all of the Shares directly owned by Kanata and 3468666.  Dr. Matthews has the sole power to vote or direct the vote and sole power to dispose or to direct the disposition of 18,000 Shares, which may be acquired by Dr. Matthews upon the exercise of outstanding stock options and 132,625 Shares, which may be acquired by Dr. Matthews upon the conversion of deferred share units.
 
Kanata does not have the sole power to vote or direct the vote and sole power to dispose or to direct the disposition of any Shares.
 
3468666 does not have the sole power to vote or direct the vote and sole power to dispose or to direct the disposition of any Shares.
 
During the last 60 days and except as setout below there were no transactions in the Shares effected by the Reporting Persons, nor any of their directors or executive officers, general partners or members.
 
Item 6.
Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer
 
Pursuant to Rule 13d-1(k) promulgated under the Act, the Reporting Persons have entered into an agreement, attached hereto as Exhibit 1, with respect to the joint filing of this statement, and any amendment or amendments hereto.
 
 
7

 
There are no contracts, arrangements, understandings, or relationships between the Reporting Persons and any other person with respect to any securities of the Issuer other than as disclosed in this Schedule 13D.
 
Item 7.                      Material to Be Filed as Exhibits
 
A.           Joint Filing Agreement
 




 
8

 
 
Signature

After reasonable inquiry and to the best of the knowledge and belief of each of the undersigned, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

November 4, 2013                                                                                                                                          
Date


/s/ Terence H. Matthews                                                                                                                                          
Signature

Dr. Terence H. Matthews                                                                                                                                          
Name/Title



KANATA RESEARCH PARK CORPORATION

/s/ Terence H. Matthews                                                                                                                                          
Signature

Dr. Terence H. Matthews, Director                                                                                                                                          
Name/Title


3468666 CANADA INC.

/s/ Terence H. Matthews                                                                                                                                          
Signature

Dr. Terence H. Matthews, President and Director                                                                                                                                          
Name/Title


The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative.  If the statement is signed on behalf of a person by his authorized representative (other than an executive officer or general partner of the filing person), evidence of the representative’s authority to sign on behalf of such person shall be filed with the statement:  provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference.  The name and any title of each person who signs the statement shall be typed or printed beneath his signature.

Attention:  intentional misstatements or omissions of fact constitute Federal criminal violations (see 18 U.S.C. 1001)


 
9

 

EXHIBIT A

JOINT FILING AGREEMENT

This confirms the agreement by and between the undersigned that the Statement on Schedule 13D (the “Statement”) filed on or about this date with respect to the beneficial ownership by the undersigned of the Common Shares, no par value, of Counterpath Corporation, is being filed on behalf of each of the undersigned.

Each of the undersigned hereby acknowledges that pursuant to Rule 13d-1(k) promulgated under the Securities and Exchange Act of 1934, as amended, each person on whose behalf the Statement is filed is individually eligible to use the schedule on which the information is filed, each person on whose behalf the Statement is filed is responsible for the timely filing of such Statement and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; and that such person is not responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.

Each of the undersigned agrees that Kanata shall be authorized to receive notices and communications on behalf of the undersigned relating to the Statement.

This Agreement may be executed in two or more counterparts by each of the undersigned, each of which, taken together, shall constitute one and the same instrument.


Dated:  November 4, 2013

By:      /s/ Terence H. Matthews                                                        
Dr. Terence H. Matthews


Dated:  November 4, 2013

KANATA RESEARCH PARK CORPORATION

By:      /s/ Terence H. Matthews                                                        
Name:   Dr. Terence H. Matthews
Title:  Director


Dated:  November 4, 2013

3468666 CANADA INC.

By:      /s/ Terence H. Matthews                                                        
Name:   Dr. Terence H. Matthews
Title:  President and Director


 
10

 

APPENDIX A
 
DIRECTORS AND EXECUTIVE OFFICERS
 

 
The following table sets forth the information required by Instruction C to Schedule 13D with respect to Kanata Research Park Corporation.

KANATA RESEARCH PARK CORPORATION
 
Name/Position
 
Business Address
 
Principal Occupation
 
Citizenship
Paul Chiarelli
Chief Executive Officer
 
390 March Road
Suite 110
Kanata, Ontario
K2K 0G7
 
President and Chief Operating Officer (Wesley Clover)
 
Canadian
Martin Vandewouw
President
 
555 Legget Drive
Suite 206
Kanata, Ontario
K2K 2X3
 
President of Kanata
 
Canadian
Patrick Ferris
Corporate Secretary
 
555 Legget Drive
Suite 206
Kanata, Ontario
K2K 2X3
 
Corporate Secretary of Kanata
 
Canadian
Dr. Terence H. Matthews
Director
 
390 March Road
Suite 110
Kanata, Ontario
K2K 0G7
 
Chairman of the Board (Mitel Networks Corporation)
 
Canadian


3468666 CANADA INC.
 
Name/Position
 
Business Address
 
Principal Occupation
 
Citizenship
Dr. Terence H. Matthews
President and Director
 
390 March Road
Suite 110
Kanata, Ontario
K2K 0G7
 
Chairman of the Board (Mitel Networks Corporation)
 
Canadian


 
11